<DOC>
	<DOC>NCT00710203</DOC>
	<brief_summary>DPN is a disorder among darkly pigmented patients, manifested by small, benign, variants of seborrheic keratoses, predominantly on the face. The purpose of this study is to determine the efficacy of a 585 nm PDL for the treatment of Dermatosis Papulosa Nigra, and compare it to therapy with curettage (scraping the lesions off) and electrodesiccation (burning the lesions off).</brief_summary>
	<brief_title>Dermatosis Papulosa Nigra</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis, Actinic</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Keratosis, Seborrheic</mesh_term>
	<mesh_term>Skin Diseases, Papulosquamous</mesh_term>
	<mesh_term>Facial Dermatoses</mesh_term>
	<criteria>Over 18 years of age. Able to give informed consent. Desires removal of lesions. Willing to come back for six week followup. Willing to fill out post operative questionnaire. At least 4 lesions less than 7 mm. Diagnosis of Dermatosis Papulosa Nigra (DPN) Less than 18 years of age. Pregnant. Sensitive to laser energy. History of Collagen Vascular Disorders. History of Keloids. History of post inflammatory hyperpigmentation. Incarcerated. Unable to give informed consent. Unable to follow up for post operative evaluation. Unable to complete patient visual analogue scale. Unable to understand consent process or risks. Unable to accept risk of scar, infection, minor bleeding, permanent or prolonged hyperpigmentation and hypopigmentation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Dermatosis Papulosa Nigra</keyword>
	<keyword>seborrheic keratoses</keyword>
</DOC>